116 related articles for article (PubMed ID: 19349857)
1. CEACAM1 expression in pancreatic endocrine tumors.
Serra S; Asa SL; Bamberger AM; Wagener C; Chetty R
Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):286-93. PubMed ID: 19349857
[TBL] [Abstract][Full Text] [Related]
2. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
Chetty R; Serra S; Asa SL
Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of CK19 and CD99 in pancreatic endocrine tumors.
Ali A; Serra S; Asa SL; Chetty R
Am J Surg Pathol; 2006 Dec; 30(12):1588-94. PubMed ID: 17122516
[TBL] [Abstract][Full Text] [Related]
4. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
Long KB; Srivastava A; Hirsch MS; Hornick JL
Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of CD99 protein expression in pancreatic endocrine tumours (PETs).
Goto A; Niki T; Terado Y; Fukushima J; Fukayama M
Histopathology; 2004 Oct; 45(4):384-92. PubMed ID: 15469477
[TBL] [Abstract][Full Text] [Related]
7. Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer.
Takeuchi A; Yokoyama S; Nakamori M; Nakamura M; Ojima T; Yamaguchi S; Mitani Y; Shively JE; Yamaue H
Sci Rep; 2019 Sep; 9(1):12702. PubMed ID: 31481751
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic and immunohistochemical correlation in sporadic pancreatic endocrine tumors: possible roles of utrophin and cyclin D1 in malignant progression.
Chang MC; Xiao S; Nosé V
Hum Pathol; 2007 May; 38(5):732-40. PubMed ID: 17306326
[TBL] [Abstract][Full Text] [Related]
9. Re-expression of CEACAM1 long cytoplasmic domain isoform is associated with invasion and migration of colorectal cancer.
Ieda J; Yokoyama S; Tamura K; Takifuji K; Hotta T; Matsuda K; Oku Y; Nasu T; Kiriyama S; Yamamoto N; Nakamura Y; Shively JE; Yamaue H
Int J Cancer; 2011 Sep; 129(6):1351-61. PubMed ID: 21413011
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in pancreatic endocrine tumors.
Srivastava A; Alexander J; Lomakin I; Dayal Y
Hum Pathol; 2001 Nov; 32(11):1184-9. PubMed ID: 11727256
[TBL] [Abstract][Full Text] [Related]
11. Expression of carcinoembryonic antigen-related cell adhesion molecule 1(CEACAM1) and its correlation with angiogenesis in gastric cancer.
Shi JF; Xu SX; He P; Xi ZH
Pathol Res Pract; 2014 Aug; 210(8):473-6. PubMed ID: 24846314
[TBL] [Abstract][Full Text] [Related]
12. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen-related cell adhesion molecule 1 is expressed and as a function histotype in ovarian tumors.
Li N; Yang JY; Wang XY; Wang HT; Guan BX; Zhou CJ
Ann Diagn Pathol; 2016 Feb; 20():7-12. PubMed ID: 26653024
[TBL] [Abstract][Full Text] [Related]
14. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors.
Schmitt AM; Anlauf M; Rousson V; Schmid S; Kofler A; Riniker F; Bauersfeld J; Barghorn A; Probst-Hensch NM; Moch H; Heitz PU; Kloeppel G; Komminoth P; Perren A
Am J Surg Pathol; 2007 Nov; 31(11):1677-82. PubMed ID: 18059224
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity in pancreatic endocrine tumors.
Tang SJ; Dumot JA; Wang L; Memmesheimer C; Conwell DL; Zuccaro G; Goormastic M; Ormsby AH; Cowell J
Am J Gastroenterol; 2002 Apr; 97(4):1022-30. PubMed ID: 12003383
[TBL] [Abstract][Full Text] [Related]
16. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy.
Brimo F; Robinson B; Guo C; Zhou M; Latour M; Epstein JI
Am J Surg Pathol; 2010 May; 34(5):715-22. PubMed ID: 20410812
[TBL] [Abstract][Full Text] [Related]
17. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
[TBL] [Abstract][Full Text] [Related]
18. The different expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) and possible roles in gastric carcinomas.
Zhou CJ; Liu B; Zhu KX; Zhang QH; Zhang TG; Xu WH; Wang HB; Yu WH; Qu YD; Wang HJ; Wu HL; Sun SZ; Guo JQ
Pathol Res Pract; 2009; 205(7):483-9. PubMed ID: 19243897
[TBL] [Abstract][Full Text] [Related]
19. Multihormonality and entrapment of islets in pancreatic endocrine tumors.
Kapran Y; Bauersfeld J; Anlauf M; Sipos B; Klöppel G
Virchows Arch; 2006 Apr; 448(4):394-8. PubMed ID: 16418841
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors.
Deshpande V; Fernandez-del Castillo C; Muzikansky A; Deshpande A; Zukerberg L; Warshaw AL; Lauwers GY
Am J Surg Pathol; 2004 Sep; 28(9):1145-53. PubMed ID: 15316313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
